Close Icon We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By continuing to use the website, you consent to our use of cookies.

Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC

This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Products:

Pharma Consulting

Close Icon

Hot topics

Thought leadership

Research and development strategy

Close Icon

Events

Conferences 2019

Awards

Upcoming Webinars

Webinar recordings

Close Icon

Global Search Configuration

Search Site Products & Services
Close Icon

Search by Keyword

Focus
Needs

Q3 Outlook Webinar: Key Catalysts and their Impact on Pharma Markets

June 10 - 16 is Cervical Screening Week 2019

Find out more

June 10 -16 is Diabetes Prevention Week

Find out more

Come meet us at the DIA Global Annual Meeting: 23-27 June 2019

Welcome to your Pharma Intelligence advantage

Market intelligence

We’re the world’s leading provider of drug, device, company, clinical trial and market intelligence in the competitive pharma and medtech markets.

News and insight

We provide unrivalled and daily-updated global insight, drawn from extensive authoritative data sets and enriched by human validation.

Data and analytics

Our premium quality data is drawn from 42,000 companies, 248,000 clinical trials in 175 countries and 65,000 drugs for 1,400 diseases.

Consultancy

Our bespoke clinical, commercial and market access solutions are designed to help you make smarter decisions that bring a better return on investment.

Global industry experts

Working in an interconnected global network, our 65 journalists and over 300 in-house analysts supply comprehensive analysis and reports.

Trusted partnerships

We’re the trusted partner of more than 3,000 companies including the top 50 pharma firms and top 10 contract research organizations.

Gold-standard service

Our customer services team will support you every step of the way so that our insight, intelligence and bespoke solutions match your needs.

Tailor-made solutions

From single reports and data downloads to enterprise subscriptions to custom consultancy, we can base our precise solutions round your exact needs.

Our Specialties

Clinical trial intelligence

Gain a competitive edge with comprehensive clinical trial intelligence. Find out what competitors are doing in key areas, understand regulations, view clinical trial and program timelines, identify sites and investigators.

Competitive and market intelligence

See the entire global biopharma and medtech market landscape in one place – our expert analysis and trusted databases cover all sectors of the industry.

business development licensing pharma intelligence

Business development and licensing

Get coverage of the latest pharmaceutical business developments, and historical metrics on financing, licensing, partnership, and acquisition.

business portfolio strategy pharma intelligence

Pharmaceutical portfolio strategy

Identify M&A targets and partnership opportunities, and develop business cases with our real-time intelligence, tools and analysis.

Regulatory approval

An increasingly complex regulatory framework for the pharmaceutical, biotech and medtech industries presents growing challenges to businesses. We’ll help you stay ahead.

medtech competitive intelligence pharma intelligence

Medtech market intelligence

To succeed in medtech, you need to have your finger on the pulse – we’ll help you access the accurate, reliable information you need.

View more
View Less

Our trusted Pharma Intelligence brands

Citeline

A Decade in Review: Oncology Trial Benchmarks and Sponsor Analysis

By Christine Blazynski, PhD 25 Jun 2019

The average cost of bringing a new drug to market continues to rise, with varying levels of investments across the highly competitive biopharmaceutical industry. To assess the potential effect of varying investments on trial activity and operations, this article reviews trial benchmarks within the active oncology therapeutic area. Industry-sponsored clinical trials across all oncology indications covered by Informa Pharma Intelligence’s Trialtrove were assessed, comparing metrics by company size based on pharma sales, and the identical benchmarks for breast cancer and rare cancers were also analyzed.

Topic Clinical trials Cancer

View white paper
Medtech Insight

Canada Proposes Stricter Postmarket Requirements

By Vibha Sharma 25 Jun 2019

The proposed regulatory changes aim to provide Health Canada with greater authority to monitor the safety of marketed devices and to take action.

Topic Policy and regulation

View article
Medtech Insight, Meddevicetracker

Artificial Intelligence, Big Data – Opportunities and Challenges for the MedTech Industry

24 Jun 2019

Digital technology is significantly changing how health care is delivered and consumed. Your job demands that you remain on top of the latest trends and market developments to stay ahead of competitors. Even more, you need context and insights to make all the rapidly changing information more meaningful.

Topic Digital Health Medtech

Single report
Medtech Insight

Multiple Reasons Why 20 Notified Bodies By Year End Looks Unlikely

By Amanda Maxwell 24 Jun 2019

The emerging notified body designation situation so far places a big question mark over the European Commission’s optimism that 20 notified bodies will be designated by the end of the year.

Topic Medtech Policy and regulation

View article
Scrip

Sanofi Google Alliance To Apply Big Data To R&D Commercial And Marketing Operations

By Joseph Haas 21 Jun 2019

Sanofi says the virtual innovation lab it will create with Google will enable precision health care and optimize R&D and commercial operations. Incoming CEO Hudson has been tasked with improving the pharma’s R&D and digital capabilities.

Topic Research Press release

View article
Scrip

AstraZeneca Plans $630m Korea Investment Amid Favorable Policies

By Jung Won Shin 20 Jun 2019

AstraZeneca plans hefty investment in South Korea’s biomedical sector over next few years, in a signal of multinationals' improved sentiment over the government’s recently announced plans to nurture the bio-health industry as a major growth engine.

Topic Company analysis Strategy

View article
Pink Sheet

Insulin Prices: House Hearing Displays Bipartisan Commitment To Rapid Reform

By Cathy Kelly 15 Jun 2019

Reform "is going to happen,” promised Energy & Commerce Oversight Subcommittee Chair Diana DeGette, suggesting the panel’s next hearing on insulin price reform may be held in July.

Topic Diabetes

View article
Scrip

Monumental Year Ahead For Korean Pharmas As New US Approvals Eyed

By Jung Won Shin 15 Jun 2019

2019 could be a monumental year for the South Korean pharma industry, as several new drug assets await the green light from the US FDA.

Topic FDA Business strategies

View article
Datamonitor Healthcare

Depression Disease Market and Forecast Analysis 2024

15 Jun 2019

Informa Pharma Intelligence is marking Depression Awareness Month with a free download of Depression Disease Market and Forecast Analysis 2024. Download your free extract from this vital report and tap into the exclusive data and insights into the depression market available only from the experts at Datamonitor Healthcare, part of the Informa Pharma Intelligence suite of tools.

Topic Drug development landscape

Single report
Datamonitor Healthcare

Better Heart Health Whitepaper

15 Jun 2019

In recognition of World Heart Day, September 29, 2018, Informa Pharma Intelligence would like to invite you to download our latest whitepaper, Better Heart Health with Mobile Apps? The Impact of Mobile Apps on Coronary Heart Disease in the US. This exploration into the results of a recent analysis of the US Behavioral Risk Factor Surveillance System (BRFSS), coupled with an analysis of several health apps targeting coronary heart disease (CHD) and other heart disease factors, is available to you now – for free.

View white paper
Scrip

Authorities Find Accounting Violation By Samsung BioLogics, Prosecutors To Probe

By Jung Won Shin 15 Jun 2019

South Korean financial authorities conclude Samsung BioLogics violated accounting standards by omitting certain information on its joint venture agreement with Biogen from public disclosures, and have ordered further investigation of a corporate governance decision on the handling in accounts of the JV, Samsung Bioepis. The latest ruling in the prolonged affair could hurt the credibility and business of Samsung BioLogics going forward, although the firm maintains it has done nothing improper.

Topic Policy and regulation

View article
Scrip

AI-Driven Drug Development Seen Blossoming In Korea As Govt Lends Support

By Jung Won Shin 15 Jun 2019

Application of artificial intelligence to new drug development in South Korea, which has been lagging in this area, is poised to accelerate as the country moves to support and encourage the technology.

Topic Drug development landscape Drug review

View article
Pink Sheet

AdvaMed Floats Legislation To Allow User-Fee Submissions During Shutdowns

By Ferdous Al-Faruque 15 Jun 2019

As the partial US government shutdown enters its second month, the backlog of device pre-market applications is building. AdvaMed is proposing language that would allow FDA to accept and review new user-fee-funded submissions during government shutdowns.

Topic US Shutdown FDA

View article
Primal Pictures

Achieving Competitive Advantage With Anatomy And Physiology

15 Jun 2019

This whitepaper explores how best in class anatomy, physiology and clinical content, images and customized solutions enable organizations to achieve strong competitive advantage, drive credibility, productivity and differentiation. We will share ideas that you can consistently apply to your own organization to reach business and revenue goals. Finally, we will conclude with a checklist of what to look for when selecting your anatomy content solution.

View white paper
Trialtrove

2017 Clinical Trials Roundup The Evolution Continues

By Doro Shin 15 Jun 2019

For a detailed look at the statistics and trends surrounding clinical trials initiated in 2017, we invite you to download 2017 Clinical Trials Roundup: The Evolution Continues. Using a wealth of trial data from Trialtrove, this information-packed white paper provides a detailed analysis of Phase I–III clinical trials that were initiated last year.

Topic Clinical trials

View white paper

Latest headlines

Pink Sheet

25 Jun 2019

Romosozumab Among Latest Drugs Up For CHMP Opinion

Link
Pink Sheet

25 Jun 2019

Russia Puts The Squeeze On Essential Drug Prices

Link
Scrip

25 Jun 2019

Cautious Restart To Venetoclax’s CANOVA Trial In Multiple Myeloma

Link
Medtech Insight

25 Jun 2019

Execs On The Move: Roche, Smith & Grail Focus On CEO Promotions And Appointments

Link
Medtech Insight

25 Jun 2019

Warning Letter Roundup & Recap – 25 June 2019

Link
Pink Sheet

25 Jun 2019

For All The Palace Intrigue, Rebate Rule, IPI Go To OMB For Review

Link
Pink Sheet

25 Jun 2019

US FDA Begins Building Pharma Industry Activity Prediction Tool

Link
Scrip

25 Jun 2019

Glenmark Boosts Respiratory Thrust In Brazil With Novartis Deal

Link
Scrip

25 Jun 2019

Vesalius’s “Proven Investment Strategy” Reflected In Largest Fund Close To Date

Link
Medtech Insight

25 Jun 2019

QUOTED. 25 June 2019. Bert van Meurs.

Link
In Vivo

24 Jun 2019

Leading From The Lab: MIT’s Robert Langer On The Converging Science Of Drugs, Devices And Delivery

Link
Scrip

24 Jun 2019

Pfizer's Talzenna To Compete With AZ's Lynparza In Breast Cancer After EU Okay

Link
Pink Sheet

24 Jun 2019

Australian Regulator: Don't Let New Ingredient Name Deadline Sneak Up On You

Link
Pink Sheet

24 Jun 2019

DSCSA Pilot Explores Feasibility Of Food Blockchain Program For Pharmaceutical Track-And-Trace Compliance

Link
Scrip

24 Jun 2019

AMAG Must Build Market For Approved Female Libido Drug To Avoid Addyi’s Fate

Link

Featured products

Trialtrove: gold standard clinical trials intelligence

Trialtrove is the go-to resource for clinical trial research. Easily track your competitors' clinical R&D activity with expert insights and continually monitored trials.

Key benefits:

Curated by experts
Clinical trial landscape view
Standard of care insights

Datamonitor Healthcare: data analysis and insight

Datamonitor Healthcare's expert coverage of key diseases, companies, drugs and market trends makes it the go-to product for pharmaceutical and biotechnology companies to support the development and validation of their strategic plans and commercial decisions.

Key benefits:

Prioritize market opportunities
Identify unmet needs
Make informed decisions

Scrip: industry news and insights

Key benefits:

Follow market developments
Go beyond the news
Hear from news makers

Upcoming events

Queensland , Australia

Industry conference

ANZAHPE 2019

Webinar